Breastfeeding Infants Show Signs Of Chemical Exposure Following Maternal Cannabis Use

Evidence links maternal cannabis use to chemical exposure in nursing infants

A new study led by researchers at Washington State University has identified a potential pathway for infant exposure to volatile organic compounds (VOCs) through breastmilk. The findings, published in the International Journal of Environmental Research and Public Health, reveal that infants whose mothers use cannabis may ingest or absorb these chemicals, which are known for their ability to evaporate easily and potentially impact human health.

The research, directed by anthropology professor Courtney Meehan, addresses a significant gap in medical literature. While maternal cannabis consumption has become more common during the perinatal period, scientific understanding of how these substances transfer to nursing infants remains limited. Many women currently turn to cannabis as a perceived safer alternative to pharmaceuticals, often making these health decisions without the benefit of comprehensive clinical data.

Tracking exposure through clinical analysis

To investigate the transfer of these compounds, the study team worked with breastfeeding participants in Washington and Oregon who reported smoking or vaping cannabis at least weekly. The protocol required mothers to provide baseline milk and infant urine samples after 12 hours of abstention, followed by a series of additional samples collected at set intervals after they resumed their regular cannabis use.

The samples were analyzed by the Centers for Disease Control and Prevention (CDC) Division of Laboratory Sciences. Researchers discovered 24 distinct VOC metabolites in the infants’ urine. Critically, every infant involved in the study showed detectable levels of at least one VOC metabolite, with concentrations trending higher in the periods following maternal cannabis use compared to the baseline samples.

The need for further health assessments

While the detection of these compounds confirms a clear exposure route, researchers urge caution regarding the interpretation of the health risks. The study was not designed to measure whether the specific concentrations found in the infants are sufficient to trigger long-term adverse health outcomes. VOCs are a broad class of chemicals, some of which are documented as hazardous, making the determination of safe exposure thresholds a priority for future investigations.

Meehan emphasizes that as societal normalization of cannabis use continues to grow, it is outpacing the scientific evidence needed to guide medical professionals and parents. Currently, families are forced to navigate these choices in a vacuum of formal guidance.

Moving forward, the research team is calling for a more rigorous examination of the long-term impacts of second- and thirdhand cannabis smoke exposure on infant development. Providing this data is essential for doctors to offer informed advice and for parents to make evidence-based decisions regarding infant health and nutrition.